Depressant effect of magnesium on early afterdepolarizations and triggered activity induced by cesium, quinidine, and 4-aminopyridine in canine cardiac Purkinje fibers

scientific article published on 01 September 1989

Depressant effect of magnesium on early afterdepolarizations and triggered activity induced by cesium, quinidine, and 4-aminopyridine in canine cardiac Purkinje fibers is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0002-8703(89)90258-5
P698PubMed publication ID2549775

P2093author name stringS Kaseda
D P Zipes
R F Gilmour
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectmagnesiumQ660
P304page(s)458-466
P577publication date1989-09-01
P1433published inAmerican Heart JournalQ2227156
P1476titleDepressant effect of magnesium on early afterdepolarizations and triggered activity induced by cesium, quinidine, and 4-aminopyridine in canine cardiac Purkinje fibers
P478volume118

Reverse relations

cites work (P2860)
Q48058451A neonatal prolonged QT syndrome due to maternal use of oral tricyclic antidepressants
Q41106514Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure
Q83931908Anthracyclines for acute lymphoblastic leukemia in a child with congenital long QT syndrome
Q46566947Choice of cardiac tissue plays an important role in the evaluation of drug-induced prolongation of the QT interval in vitro in rabbit
Q74695277Cytosolic Ca2+ triggers early afterdepolarizations and Torsade de Pointes in rabbit hearts with type 2 long QT syndrome
Q51677363Early Afterdepolarization in a Patient with Complete Atrioventricuiar Block and Torsades de Pointes
Q42279684Effective use of magnesium for acquired torsade de pointes in a 4-month-old infant
Q37011111Fever accentuates transmural dispersion of repolarization and facilitates development of early afterdepolarizations and torsade de pointes under long-QT Conditions
Q68309076Giant U waves and associated ventricular tachycardia complicating astemizole overdose: Successful therapy with intravenous magnesium
Q72309434Hemodynamic effects of 3,4-diaminopyridine in a swine model of verapamil toxicity
Q41032270Ionic mechanisms of ischemia-related ventricular arrhythmias.
Q40795208Magnesium and the heart: antiarrhythmic therapy with magnesium
Q44234477Modulation of cardiac action potential and underlying ionic currents by the pyrethroid insecticide deltamethrin
Q28272296Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide
Q64972571Prevention of Cardiovascular Disease: Screening for Magnesium Deficiency.
Q34027347Proarrhythmia, a serious complication of antiarrhythmic drugs
Q51459007Prophylactic magnesium to decrease the arrhythmogenic potential of class III antiarrhythmic agents in a rabbit model.
Q37013934Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients
Q44689852Sensitivity and specificity of isolated perfused guinea pig heart to test for drug-induced lengthening of QTc.
Q28316842Sotalol-induced torsade de pointes: management with magnesium infusion
Q24296910Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak
Q33895866The ionic mechanism of reperfusion-induced early afterdepolarizations in feline left ventricular hypertrophy
Q48527508Usefulness of magnesium sulfate in stabilizing cardiac repolarization in heart failure secondary to ischemic cardiomyopathy
Q73795648[Effect of magnesium on sustained ventricular tachycardia]
Q73795659[Medicamentous anti-arrhythmia therapy. Is oral adjuvant therapy with electrolytes of value?]

Search more.